Outsourcing-Pharma RSS

SNBL invests in animal welfare at US lab

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Wed, 16 May 2012 12:52:32 +0200

SNBL USA has invested in ‘social housing’ at its lab in Everett, Washington citing ‘recent reductions’ in US non-human primate lab capacity as the driver.

IGI hires after “notable shift” in pharma services demand

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Wed, 16 May 2012 12:11:56 +0200

IGI Laboratories has boosted hiring after its pharmaceutical contract manufacturing unit experienced a “notable shift” in demand.

Contract sales deals expirations drive drop in revenues at PDI

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Wed, 16 May 2012 15:52:09 +0200

Expiration of contract sales deals drove a 28 per cent drop in revenue at PDI and pushed financials below analysts’ expectations.

Quality research key to Pharma viability say execs at Avoca Summit

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Wed, 16 May 2012 17:20:50 +0200

Ensuring outsourced clinical research is of a high standard is critical to the viability of the pharma sector and requires cross industry collaboration according to leaders gathered at the Avoca Group’s Quality Summit.

SNBL fixes probs at Everett lab; animal shipment blocked by Israeli courts

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Tue, 15 May 2012 13:40:42 +0200

Preclinical services firm SNBL has fixed most of the deficiencies observed during a US FDA inspection in 2010 and says it is working to ‘quickly’ resolve the remaining issues.

INC selects Trial Interactive as global eTMF system

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Tue, 15 May 2012 12:15:40 +0200

INC Research has chosen Trial Interactive from TransPerfect as its global electronic trial master file (eTMF) system.

Patheon launches CMC consultancy in face of restructuring plans

Natalie.MORRISON@wrbm.com (Natalie MORRISON) — Tue, 15 May 2012 16:54:50 +0200

Patheon has launched a new consulting service designed to give emerging biotechs and pharmas a boost in their drug development efforts.

Sales slump prompts BASi to plan more cost cutting steps

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Tue, 15 May 2012 15:47:49 +0200

BASi is planning further cost cutting actions after continued weakness in toxicology led to a double-digit drop in revenue.

Vetter opens logistics warehouse and secures loan

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Mon, 14 May 2012 13:15:55 +0200

CDMO Vetter Pharma International has opened a new temperature-controlled warehouse and secured a multimillion Euro loan for further investment.

Client insourcing hits Catalent packaging services sales in Q3

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Mon, 14 May 2012 12:30:46 +0200

Catalent reported a dip in third quarter contract packaging sales and volumes after a client insourced work.

Manufacturing & lab demand help WuXi beat Q1 guidance

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Mon, 14 May 2012 11:33:14 +0200

WuXi PharmaTech beat expectations in the first quarter as strong demand for manufacturing and laboratory services continued.

Marken mulls direct-to-study participant distribution

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Mon, 14 May 2012 12:13:25 +0200

Marken is looking at setting up a home delivery service as a further expansion of its clinical trial and logistics offering.

DSM’s says CMO sales up in Q1, but predicts challenging 2012

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Thu, 10 May 2012 12:53:26 +0200

DSM saw some improvement for its CMO business in Q1 2012, but says the market will continue to be a challenge.

USDA asks MPI to reconfigure enclosures after animal death

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Thu, 10 May 2012 10:30:20 +0200

MPI Research must reconfigure its enclosures after they led to the death of a non-human primate, a USDA report obtained by animal rights activists shows.

Patheon warns 400 jobs at risk as Swindon site trimmed

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Thu, 10 May 2012 11:51:29 +0200

Patheon may lay off 400 staff at its Swindon, UK site as it moves forward with the restructuring of its facilities.

New online GLP investigator training module for Icon

Natalie.MORRISON@wrbm.com (Natalie MORRISON) — Wed, 09 May 2012 13:13:14 +0200

Icon has launched a new online GCP (good clinical practice) teaching module that it says will improve the compliance of investigator training.

Know how your CMO will deliver its promises, says Baxter

Natalie.MORRISON@wrbm.com (Natalie MORRISON) — Wed, 09 May 2012 12:17:39 +0200

“Understand not only what your CMO can do, but how they can get it done,” was Baxter’s message during a speech at the year’s Interphex in New York.

FDA oversight driving closures of CMOs; Interphex speaker

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Wed, 09 May 2012 16:29:58 +0200

Increased oversight by the FDA is causing some US-based CMOs to shut down, a speaker at Interphex said.

US biotech pursues Cetero for drug development delay costs

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Wed, 09 May 2012 11:15:08 +0200

A US biotech is seeking $250,000 from Cetero to cover drug development delays caused by alleged breaches of contract.

SGS adds formulation development services and expands US lab

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Mon, 07 May 2012 12:15:55 +0200

SGS has added formulation development to its service offering through the expansion of its laboratory in Illinois.